Authors

• Chenyu Mao (ORCID: https://orcid.org/0000-0003-1801-5406)
• Caicun Zhou (ORCID: https://orcid.org/0000-0002-2246-5541)
• Jiong Qian
• Sixiang Long
• Zhihai Wu (ORCID: https://orcid.org/0000-0001-7293-9250)
• Haiqing Ni
• Tao Zhang (ORCID: https://orcid.org/0000-0001-8713-0796)
• Li Zhao (ORCID: https://orcid.org/0000-0001-9308-6808)
• Wenxiang Wang (ORCID: https://orcid.org/0009-0002-9542-7746)
• Yuling Chen (ORCID: https://orcid.org/0000-0003-3852-9041)
• Jia Lu (ORCID: https://orcid.org/0000-0002-9001-5147)
• Anwen Xiong
• Nong Xu (ORCID: https://orcid.org/0009-0001-2545-4370)
• Ying Liu (ORCID: https://orcid.org/0000-0002-8859-9585)

Institutions

• Hunan Cancer Hospital (CN)
• Shanghai East Hospital (CN)
• Wuhan Union Hospital (CN)
• Henan Cancer Hospital (CN)
• First Affiliated Hospital Zhejiang University (CN)

Publication Details

Journal

Journal of Hematology & Oncology

Published

2024-12-31

DOI

https://doi.org/10.1186/s13045-024-01651-5

Citations

13

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

3.67

Funders

• Innovent Biologics